Veriheal

FEBRUARY 28, 2022

Fortunately, Chinese scientists have developed non-hallucinogenic antidepressant compounds. A press release announcing the scientists’ research explains that the team has “designed two new compounds that can relieve depression but do not cause the unwanted effect of hallucination.” A New Kind of Depression Treatment.

Research and Development 98

Research and Development Treatment Therapy Environment 98

Veriheal

FEBRUARY 14, 2024

In a recent hearing, the Arizona Senate Health and Human Services Committee unanimously approved a bill that would legalize therapeutic psilocybin centers for medically supervised use. This will also include licensing for centers that are working on psilocybin and psychedelic research.

Therapy 62

Therapy Legalization Research and Development Treatment 62

Veriheal

NOVEMBER 24, 2021

For the first time ever, researchers will conduct a comprehensive state population health analysis to understand the impact of medical cannabis on consumers’ healthcare —and it’s all happening in Arkansas. The post Researchers To Investigate Arkansas’ Medical Cannabis Program appeared first on Cannabis Central.

Programs 98

Programs Research and Development Data Dispensary 98

Veriheal

MAY 18, 2023

New guidelines for cannabis in chronic pain were recently published by a group of Canadian researchers. Featured in the journal Cannabis and Cannabinoid Research , the guidelines were compiled after researchers perused scientific databases for peer-reviewed English articles on cannabis and pain. used it in the last month.

Chronic Pain 98

Chronic Pain Treatment Research and Development Patients 98

Cannabis Law Report

JUNE 18, 2021

CanMar Recruitment is looking for a Director of Business Development and Partnerships for our client in Montreal, Quebec. As Director of Business Development and Partnerships, you are responsible for leading and accelerating business analysis, sourcing, and deal flow activities. About Our Client. About the Role. Responsibilities.

Business 104

Business Research and Development Advocacy Data 104

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

APRIL 28, 2022

Get a bunch of researchers to research it, publish a report for committees to mull over and then ignore. The researchers leading the study were all affiliated with The University of Queensland , and they examined, “historical changes in legalization attitudes and the period-specific individual and external influences on these.”. “A

Legalization 52

Legalization Research and Development Media Data 52

Cannabis Law Report

FEBRUARY 28, 2022

In the past two decades, pioneering research has rekindled interest in the therapeutic use of psychedelic substances such as psilocybin, ibogaine, and dimethyltryptamine (DMT). Indigenous communities have used them for centuries, and researchers studied them in the 1950s and ‘60s. Glenn Cohen & Mason Marks. 20 February 2022.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Medical Marijuana Program Connection

JANUARY 18, 2024

Legal Marijuana Market AMR PORTLAND, OR, UNITED STATE, January 19, 2024 /EINPresswire.com/ — Allied Market Research added new research on Global Legal Marijuana Market– Global Opportunity Analysis and Industry Forecast, 2022–2030.

Research and Development 49

Research and Development Legalization Marijuana 49

NewsMunchies

JULY 10, 2023

Artificial intelligence is a smarter, faster, and more effective pathway to drug development. With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds major potential to increase the accessibility of drugs and to treat diseases and conditions.

Treatment 58

Treatment Research and Development Pharmaceutical Microdosing 58

Veriheal

JUNE 22, 2020

Whether or not cannabis use during pregnancy causes physical, cognitive, or mental impairments later in life has been something scientists and researchers have been investigating for decades. Unfortunately, much of the research conducted thus far have not shown the whole picture or clinical implications for children in real life.

Research and Development 98

Research and Development Data Policy Education 98

Veriheal

AUGUST 16, 2021

The National Football League has taken proactive steps moving forward into the future with a research grant to explore potential therapeutic attributes of CBD, cannabis, and other options to treat pain other than opioids. Not bad for an industry that hasn’t been in legal business since the 1940s. The opioid epidemic is real.

Therapy 104

Therapy Chronic Pain Research and Development Treatment 104

Veriheal

MARCH 17, 2022

However, new research has found that psychedelic use is only “weakly associated with psychosis-like symptoms.” New Research Published on Serotonergic Psychedelic Use and Psychosis. New Research Published on Serotonergic Psychedelic Use and Psychosis. The research team under the leadership of Alexander V.

Research and Development 98

Research and Development Therapy Conditions History 98

Veriheal

DECEMBER 9, 2021

When cannabis legalization began to gain ground and support, those who remained opposed to these policy changes touted claims that legalization would increase the risk of mental illness or even suicide among affected populations. Support From Other Studies.

Legalization 98

Legalization Research and Development Consumption Recreational 98

Cannabis Law Report

NOVEMBER 1, 2021

In the past few decades, pioneering research has rekindled interest in the therapeutic use of psychedelic substances such as psilocybin, ibogaine, and dimethyltryptamine (DMT). Indigenous communities have used them for centuries, and researchers studied them in the 1950s and 60s. Date Written: October 23, 2021. war on drugs.

Research and Development 52

Research and Development Law Clinical Trials Therapy 52

Veriheal

NOVEMBER 30, 2021

Veriheal does not support illegally consuming therapeutic substances such as psilocybin but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies.

Research and Development 98

Research and Development Therapy Data Treatment 98

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

OCTOBER 7, 2021

We also asked Greg Rovner, CEO of Heally the same series of questions about the hoped for boost to research in Florida. However, we support any research-based attempts to legalize psychedelics as well as any research into them. . We hope this research spurs regulatory reform in the psychedelic space.

Legislation 105

Legislation Research and Development Treatment Therapy 105

Cannabis Law Report

MAY 29, 2022

is a Canadian company that researches, develops and grows psilocybin-producing mushrooms and functional mushrooms. A new cultivation facility that is hoping to change lives with psychedelic mushrooms had their grand opening on Friday in Princeton, after being awarded a dealer’s license in February by Health Canada.

Research and Development 52

Research and Development Clinical Trials Medicine Access 52

Cannabis Law Report

NOVEMBER 22, 2021

Thailand’s Public Health Ministry has signed a Memorandum of Understanding (MOU) with RxLeaf World Medica on establishing the International Medical Cannabis Research Center. The latest movement is a part of Thailand’s plan to be a world-class cannabis production and development hub. For more information [link].

Research and Development 52

Research and Development Epilepsy Cannabis Food 52

Cannabis Law Report

MARCH 24, 2022

The Senate on Thursday unanimously approved a marijuana bill—but not the federal legalization measure that advocates have been eagerly awaiting Senate Majority Leader Chuck Schumer (D-NY) to bring to the floor. Rather, it’s a modest bipartisan piece of legislation that’s simply meant to promote research into marijuana.

Research and Development 52

Research and Development Legislation Patients Safety 52

Cannabis Law Report

DECEMBER 22, 2020

ZYUS is a Canadian-based, next-generation life sciences company leading scientific research and development in phyto-therapeutics. The post Senior Legal Counsel ZYUS – Saskatoon, SK first appeared on Cannabis Law Report. We are committed to delivering high-quality standardized therapeutic formulations that … Read More.

Research and Development 98

Research and Development Legalization Law Cannabis 98

Cannabis Law Report

JUNE 7, 2021

(CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), today announced that it has received its Cannabis Research Licence under Health Canada’s Cannabis Act and Cannabis Regulations through its wholly-owned subsidiary, Voyage Cannabis Corp. and ArthroCBD.

Research and Development 95

Research and Development Extraction Recreational Topical 95

MMJ Recs

FEBRUARY 27, 2024

As the state continues to navigate the complexities of legalization, patients, dispensaries, and the cannabis industry are witnessing significant changes. Medical marijuana is being researched for its potential to alleviate symptoms such as tremors and improve the quality of life for individuals with Parkinson’s disease.

Dispensary 93

Dispensary Legalization Marijuana Therapy 93

Cannabis Law Report

JUNE 3, 2021

The agreement builds on an existing partnership between the FRB, CRAG, and IRTA formed in 2019 to develop research tools for the genetic improvement of cannabis plants. The extended partnership provides FRB the opportunity to establish their expertise as a global leader in cannabis genetics and breeding.

Agriculture 98

Agriculture Research and Development Supply Chain Hemp 98

Veriheal

JUNE 22, 2021

The Ames Tribune explains that professor Jacek Koziel began his research on the smell from cannabis when he was exposed to bags of confiscated cannabis. The cannabis was donated for research to the State Forensics Laboratory in Ankeny. . The cannabis was donated for research to the State Forensics Laboratory in Ankeny. .

Research and Development 92

Research and Development Agriculture Strains Cannabis 92

Cannabis Law Report

OCTOBER 4, 2021

A major component of the program will be the development of new ways to infuse both the psychedelic compounds and fungi components into products to both improve bioavailability and to mask the bitter tastes of the fungus and its components. ” About Provisional Patent Filings.

Food 52

Food Programs Research and Development Collective 52

Cannabis Law Report

MARCH 25, 2020

OTCQB: AXIM) (“AXIM® Biotech” or “AXIM”) has completed the acquisition of leading oncology research and development company Sapphire Biotech, Inc. (“Sapphire”). Valencia has stewarded Sapphire in the development of its unique patent-pending pipeline. About AXIM® Biotechnologies.

Research and Development 59

Research and Development Supply Chain Pharmaceutical Clinical Trials 59

The Cannigma

JUNE 19, 2022

Recreational cannabis is not legal in Colombia, but personal consumption and possession of the plant is decriminalized. Adult-use cannabis is not legal, but in 2012, the Colombian government decriminalized personal use of cannabis and possession of up to 20 grams. The country has had a medical cannabis program since 2015.

Legalization 97

Legalization Decriminalization Research and Development Consumption 97

SpeedWeed

MAY 18, 2021

Drug Enforcement Administration (DEA) quietly made an announcement that’s expected to have a profound and long-lasting impact on cannabis research and development in the United States. cannabis researchers. For years, NIDA and the DEA have promised to open up the sourcing of federally-approved research cannabis.

DEA 52

DEA Research and Development Data Cannabis 52

Veriheal

APRIL 26, 2022

Growth of the worldwide legal cannabis market is unlikely to slow down anytime soon, according to the findings of a new report published by analysts at Research and Markets. In 2020, legal cannabis constituted a $12.8 Global Legal Cannabis Market Divergence & Scope. billion by 2026. billion by 2026.

Supply Chain 98

Supply Chain Legalization Research and Development Chronic Pain 98

WeedAdvisor

JULY 4, 2019

Drug Enforcement Administration is not a fan of drugs or legalization. Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. The Wrong Type of Cannabis. .

DEA 111

DEA Research and Development Clinical Trials Cultivation 111

Cannabis Law Report

JULY 30, 2022

City and county governments may also refer ordinances with a sunset clause that essentially act as a temporary moratorium on psilocybin businesses to provide local governments the opportunity to develop time, place, and manner (TPM) restrictions.

Business 52

Business Research and Development Compliance Compliance 52

Veriheal

AUGUST 24, 2022

Colorado could legalize psychedelics. These include legalizing the possession, cultivation, use, and sharing of psychedelic components such as ibogaine , mescaline , DMT, psilocybin , and psilocin for adults over the age of 21. Research and Testimonials Point to Psychedelics’ Therapeutic Benefits. city to do so.

Legalization 109

Legalization Decriminalization Medicine Research and Development 109

Cannabis Law Report

APRIL 17, 2022

billion) annually to state revenue, Minister for Development and Investment Adonis Georgiadis said, according to greekreporter.com. Tikun Europe was established in Greece in 2018 and is a subsidiary of the Israeli Tikun Olam global player in the research and development of medical cannabis products. billion euros ($1.67

Research and Development 52

Research and Development Chronic Pain Recreational Environment 52

SpeedWeed

JULY 23, 2021

Denver is expanding Alzheimer’s research through the efforts of local company MedPharm. . The company plans to move forward with research efforts through a special Schedule I Researcher Licenses given specifically to the company by the Drug Enforcement Administration. Denver Company Moves Forward with Research License .

Clinical Trials 52

Clinical Trials Research and Development DEA Cannabinoids 52